CureVac NV (CVAC)
4.185
+0.90
(+27.20%)
USD |
NASDAQ |
May 22, 10:48
CureVac Total Liabilities (Quarterly): 299.90M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 299.90M |
| September 30, 2023 | 254.36M |
| June 30, 2023 | 272.16M |
| March 31, 2023 | 283.81M |
| December 31, 2022 | 350.91M |
| September 30, 2022 | 280.64M |
| June 30, 2022 | 316.11M |
| March 31, 2022 | 392.65M |
| Date | Value |
|---|---|
| December 31, 2021 | 531.88M |
| September 30, 2021 | 1.123B |
| June 30, 2021 | 1.149B |
| December 31, 2020 | 983.98M |
| September 30, 2020 | 305.91M |
| March 31, 2020 | 219.83M |
| December 31, 2019 | 194.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
194.26M
Minimum
Dec 2019
1.149B
Maximum
Jun 2021
463.88M
Average
305.91M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 43.50M |
| InflaRx NV | 13.32M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 2.471B |
| Immatics NV | 272.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 871.33M |
| Shareholders Equity (Quarterly) | 571.43M |
| Current Ratio | 2.567 |